washingtonpost.com > Business > Local Business
Your Comments On...

Novavax Moves Closer to Licensing Bird Flu Vaccine

Novavax said yesterday that its bird flu vaccine elicited a robust immune response in humans, moving the biotech a step closer to licensing its pandemic vaccine production system.
 - 

By Kendra Marr

 
Comments
© 2008 The Washington Post Company